CIGNA CORPORATION

(CI)
  Report
Delayed Nyse  -  04:00 2022-08-08 pm EDT
281.77 USD    0.00%
11:25aUBS Adjusts Cigna Price Target to $330 From $310, Maintains Buy Rating
MT
10:38aCredit Suisse Lifts Cigna's Price Target to $329 from $315, Raises Estimates After Q1 Outperformance; Maintains Outperform Rating
MT
08:56aWALL STREET STOCK EXCHANGE : Lost in inflation
MS
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Cigna Corporation(NYSE:CI) added to Russell 1000 Defensive Index

06/24/2022 | 12:00am EDT

Cigna Corporation(NYSE:CI) added to Russell 1000 Defensive Index


© S&P Capital IQ 2022
All news about CIGNA CORPORATION
11:25aUBS Adjusts Cigna Price Target to $330 From $310, Maintains Buy Rating
MT
10:38aCredit Suisse Lifts Cigna's Price Target to $329 from $315, Raises Estimates After Q1 O..
MT
08:56aWALL STREET STOCK EXCHANGE : Lost in inflation
MS
08:43aWells Fargo Adjusts Cigna's Price Target to $319 From $306, Reiterates Overweight Ratin..
MT
07:58aCigna Reports Strong Second Quarter 2022 Results, Raises 2022 Outlook
AQ
05:47aANALYST RECOMMENDATIONS : Cigna, Duke Energy, Vertex Pharmaceuticals, EOG Resources, Motor..
MS
08/05Mizuho Securities Raises Price Target on Cigna to $330 From $291, Reiterates Buy Rating
MT
08/05Oppenheimer Adjusts Cigna Price Target to $320 From $310, Maintains Outperform Rating
MT
08/05Deutsche Bank Adjusts Cigna Price Target to $312 From $284, Maintains Hold Rating
MT
08/05RBC Raises Price Target on Cigna to $294 From $272, Maintains Sector Perform Rating
MT
More news
Analyst Recommendations on CIGNA CORPORATION
More recommendations
Financials (USD)
Sales 2022 180 B - -
Net income 2022 5 294 M - -
Net Debt 2022 23 956 M - -
P/E ratio 2022 16,4x
Yield 2022 1,53%
Capitalization 85 973 M 85 973 M -
EV / Sales 2022 0,61x
EV / Sales 2023 0,57x
Nbr of Employees 72 963
Free-Float 78,7%
Chart CIGNA CORPORATION
Duration : Period :
Cigna Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CIGNA CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 281,77 $
Average target price 307,13 $
Spread / Average Target 9,00%
EPS Revisions
Managers and Directors
David Michael Cordani Chairman, President & Chief Executive Officer
Brian C. Evanko Chief Financial Officer & Executive Vice President
Noelle K. Eder Global Chief Information Officer & Executive VP
Paul Sanford Executive Vice President-Operations
William J. DeLaney Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CIGNA CORPORATION22.71%85 973
UNITEDHEALTH GROUP6.56%500 486
ANTHEM, INC.2.50%114 032
HUMANA INC.4.35%61 255
CENTENE CORPORATION12.92%53 181
MOLINA HEALTHCARE, INC.2.15%18 877